Trenbolone Enanthate 200 mg Cygnus | EPC-0233

Trenbolone Enanthate (Trenbolone Enanthate 200 mg)

Trenbolone enanthate has an anabolic and androgenic effect, the drug is weakly manifested in the prostate gland, the skin of the human body and head; neither acne, nor alopecia, nor severe hair loss on the face and body are manifested when taken in the recommended dosages. Despite this, taking large doses can provoke similar effects. In addition, trenbolone does not have very pronounced progestogenic activity, it can within some limits (sometimes quite strongly) reduce libido when taking the drug, but in practice this has almost never been observed, on the contrary, the sexual desire of the athlete increases several times, as well as physical strength (with the appropriate class of the athlete).

The ability of trenbolone to stabilize the androgen receptor is 5 times stronger (compared to testosterone), which indicates that the drug is a good anabolic. It also, like testosterone, produces an anabolic effect. It manifests itself in stimulating protein synthesis, reducing fat deposition, retaining potassium, phosphorus and sulfur in the body, which are necessary for protein synthesis, increasing the fixation of calcium in the bones, and increasing muscle mass. In addition, the drug significantly increases the synthesis of IGF in the liver.

• Activity of the substance: 2 weeks
• Classification: Steroid of anabolic / androgenic origin
• Method of use: by injection
• Doses: Men from 100 to 300 mg per week. / Not recommended for women
• Acne: Yes (more dependent on predisposition) Water
• Retention: No
• High blood pressure: Yes
• Hepatotoxicity: None
• Aromatase: None

Progestogenic activity: present

• DHT (Dehydrotestosterone) Conversion: No
• Decrease in HPTA (Self-Testosterone Production) Function: Yes
• Anabolic Activity (400%)\ Androgenic activity (200%) detection time – 8-9 weeks (approximately, due to the fact that DK will improve methods for the detection of illicit substances as well as this depends on the athlete, whether it takes phenobarbital and furosemide to accelerate excretion of the drug):
• Increases muscle mass (up to 10 kg in an 8 week course of trenbolone)
• Improves strength
• Affects the increase in the level of insulin-like growth factor (aka IGF or somatomedin) by 200%
• Promotes fat burning both independently and by stimulating the secretion of IGF
• Increases libido during the course, provides a significant reduction after the course (if gonadotropin and nolvadex are not used, PCT (post-course therapy with tamoxifen (or its analogues, for example, toremifene or clomiphene citrate) and gonadotropin after a course of trenbolone-mandatory
• Reduces cortisol levels